[1] |
EUGSTER A K, NAIRN C. Diarrhea in puppies:parvovirus like particles demonstrated in their feces[J]. South West Vet, 1977, 30(1):59-60.
|
[2] |
AGUNGPRIYONO D R, UCHIDA K, TABARU H, et al. Subacute massive necrotizing myocarditis by canine parvovirus type 2 infection with diffuse leukoencephalomalacia in a Puppy[J]. Vet Pathol, 1999, 36(1):77-80.
|
[3] |
MEUNIER P C, COOPER B J, APPEL M J G, et al. Pathogenesis of canine parvovirus enteritis:sequential virus distribution and passive immunization studies[J]. Vet Pathol, 1985, 22(6):617-624.
|
[4] |
FOCOSI D, ANDERSON A O, TANG J W, et al. Convalescent plasma therapy for COVID-19:state of the art[J]. Clin Microbiol Rev, 2020, 33(4):e00072-20.
|
[5] |
周灵, 梁琳, 王宏伟, 等. 犬细小病毒免疫球蛋白对犬细小病毒中和活性的研究报告[J]. 中国兽医科学, 2016, 46(8):1009-1014.ZHOU L, LIANG L, WANG H W, et al. Report on neutralization tests of immunoglobulin against canine parvovirus[J]. Chinese Veterinary Science, 2016, 46(8):1009-1014. (in Chinese)
|
[6] |
姜旭, 赵健, 倪婷婷, 等. 犬细小病毒免疫球蛋白的有效性评价[J]. 实验动物科学, 2020, 37(5):9-13.JIANG X, ZHAO J, NI T T, et al. Evaluation of the effectiveness of canine parvovirus immunoglobulin[J]. Laboratory Animal Science, 2020, 37(5):9-13. (in Chinese)
|
[7] |
李六金, 屈红丽, 姜焕宏, 等. 抗犬细小病毒免疫球蛋白临床应用研究[J]. 中国兽药杂志, 2003, 37(3):46-47, 32.LI L J, QU H L, JIANG H H, et al. Application of anti-canine-parvovirus immunoglobuline in the treatmeat of CPV infection[J]. Chinese Journal of Veterinary Drug, 2003, 37(3):46-47, 32. (in Chinese)
|
[8] |
GOODING G E, ROBINSON W F. Maternal antibody, vaccination and reproductive failure in dogs with parvovirus infection[J]. Aust Vet J, 1982, 59(6):170-174.
|
[9] |
DECARO N, DESARIO C, ELIA G, et al. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c[J]. New Microbiol, 2008, 31(1):125-130.
|
[10] |
SHIMA F K, OMOBOWALE T O, ADESINA R D, et al. Molecular characterisation of canine parvoviruses from clinical samples and vaccines in Nigeria[J]. Infect Genet Evol, 2020, 85:104553.
|
[11] |
BATTILANI M, MODUGNO F, MIRA F, et al. Molecular epidemiology of canine parvovirus type 2 in Italy from 1994 to 2017:recurrence of the CPV-2b variant[J]. BMC Vet Res, 2019, 15(1):393.
|
[12] |
SPIBEY N, GREENWOOD N M, SUTTON D, et al. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus[J]. Vet Microbiol, 2008, 128(1-2):48-55.
|
[13] |
SIEDEK E M, SCHMIDT H, STURE G H, et al. Vaccination with canine parvovirus type 2(CPV-2) protects against challenge with virulent CPV-2b and CPV-2c[J]. Berl Munch Tierarztl Wochenschr, 2011, 124(1-2):58-64.
|
[14] |
DAY M J, HORZINEK M C, SCHULTZ R D. WSAVA guidelines for the vaccination of dogs and cats[J]. J Small Anim Pract, 2010, 51(6):e1-e32.
|